Editorial Article: Taking place today! Round table debate on cell and gene therapies’ longevity and compliance

Hear from leading scientists how they are bringing the promise of customized medicine to life, and discover the key players in an industry that is shaping the future of cell and gene therapy

27 Feb 2024

SelectScience® is hosting a round table debate on the longevity and compliance of cell and gene therapies – a new Accelerating Science Forum event – today (February 27, 2024) – and invites you to attend.

Industry experts Dr. Priya Chockalingam, Dr. Torsten Wuestefeld, and Jay Tanna will explore the potential of innovative cell and gene therapy types alongside the recent critical approvals of Casgevy™ and Lyfgenia™, monitoring long-term efficacy, identifying potential risks, improving manufacturing processes, optimizing dosing regimens, and developing robust monitoring systems.

Whether you are a researcher, healthcare professional, industry representative, or simply interested in the future of medicine, this event, sponsored by LGC Biosearch Technologies and Bio-Techne, will equip you with valuable knowledge and understanding of the challenges and potential solutions related to the longevity and compliance of cell and gene therapies.

Register for free now >>
Dr. Priya Chockalingam, Dr. Torsten Wuestefeld, and Jay Tanna
(L to R) Dr. Priya Chockalingam, Vice President, Head of Clinical Bioanalytics and Translational Sciences, Beam Therapeutics
Dr. Torsten Wuestefeld, Associate Professor of Molecular Metabolism at the Lee Jong Chan School of Medicine, Nanyang Technological University / Group Leader of the Laboratory of In Vivo Genetics and Gene Therapy

Jay Tanna, Quality Assurance Manager, Cellular Therapy Laboratory, The US Children’s National Hospital

To find out more about cell and gene therapies go to our Cell and Gene Therapy Accelerating Science feature. The feature covers four pivotal topics: 

1. How gene editing heralds new therapeutic era
Explore the powerful gene editing technologies and next generation of tools, from CRISPR and TALENs to ZFNs and beyond. 

2. Breakthrough therapies to transform healthcare
Discover revolutionary treatments and new therapeutic options, including the recent approval of Casgevy and Lyfgenia for the treatment of sickle cell disease. 

3. Innovative gene delivery for targeted therapeutics
Compare the available gene delivery systems for your therapeutics and evaluate the advantages of viral versus non-viral vectors for safe and efficacious therapy delivery. 

4. Who are the innovators of future cell and gene therapies and personalized medicine?
Find out how experts are bringing the promise of customized medicine to life and discover the key players in an industry that is shaping the future of cell and gene therapy through innovative technology. 

You can also register to attend the round table debate here.